TL;DR
This study investigates the intriguing inverse relationship between cancer and Alzheimer's Disease (AD) by analyzing genetic predispositions. Using pathway-specific polygenic risk scores (PRS), researchers identified specific biological pathways that may underlie this association, offering new avenues for understanding AD pathogenesis and potential therapeutic targets.
What Problem Does This Paper Address?
Recent observations suggest that individuals with a history of cancer may have a lower risk of developing Alzheimer's Disease (AD). This inverse relationship is puzzling, and while several hypotheses exist – involving common signaling pathways, hormonal systems, and genetic factors – the precise mechanisms remain unclear. This paper aims to shed light on this by exploring the genetic underpinnings of this association. Specifically, it investigates whether genetic susceptibility, as measured by polygenic risk scores (PRS) focused on biological pathways, can explain the observed inverse relationship between cancer and AD neuropathologic changes.
Methods
The researchers employed a pathway-specific polygenic risk score (PRS) analysis. This approach involves:
- Gene Ontology (GO) Mapping: Genes were mapped to GO categories to identify biological processes. The study focused on GO categories with three or more genes, ultimately identifying 7,300 biological processes.
- Pathway-Specific PRS Calculation: For each of the five cancer types studied, PRS were calculated based on genes within specific biological pathways.
- Association Analysis: These pathway-specific PRS were then analyzed for their association with AD neuropathologic changes. The APOE region, a known strong genetic risk factor for AD, was excluded from the analysis to focus on other genetic influences.
- Neuropathologic Evaluation: AD neuropathologic changes were assessed using data from the National Alzheimer's Coordinating Center (NACC), specifically focusing on Thal phase, Braak NFT Stage, and CERAD score.
This method is novel in its application of pathway-specific PRS to explore the cancer-AD inverse relationship, moving beyond general PRS to pinpoint biological mechanisms.
Datasets
The study utilized the following datasets:
- National Alzheimer's Coordinating Center (NACC): Provided phenotype data for AD patients.
- Alzheimer's Disease Genetics Consortium (ADGC): Provided genotype data.
- UK Biobank: Provided summary statistics for five cancer types: liver, lung, prostate, breast, and colon cancers.
No new benchmarks were introduced; rather, existing large-scale genetic and clinical datasets were leveraged.
Key Insights and Ideas
- Pathway-Level Genetic Insights: The study moves beyond single-gene associations to explore how entire biological pathways, when considered genetically, relate to both cancer and AD. This is crucial because complex diseases like AD are likely influenced by the interplay of multiple genes within specific biological systems.
- Potential Mechanistic Links: By identifying specific pathways associated with both cancer PRS and AD pathology, the research offers concrete biological hypotheses for the observed inverse relationship. This is a significant step from simply observing a correlation to suggesting underlying biological mechanisms.
- Beyond APOE: The exclusion of the APOE region is important. While APOE is a major AD risk factor, this study's focus on other genetic pathways allows for the discovery of novel associations not driven by this well-known locus.
Key Results
The study identified several significant biological pathways associated with cancer PRS and AD neuropathologic changes:
- Cell Cycle and Apoptosis: Cell cycle-related pathways and apoptotic pathways showed the most significant associations with AD neuropathologic changes (specifically C scores and B scores). This suggests that disruptions in how cells divide and die might be a common thread.
- Angiogenesis and Atherosclerosis: Angiogenesis pathways were positively associated with TDP-43 pathology, while atherosclerosis pathways were linked to cerebrovascular pathologies. These findings point to potential roles for vascular health and blood vessel formation in the complex interplay between cancer and AD.
- Specific Cancer-Pathology Links: Table 1 details specific associations, such as:
- Prostate cancer PRS related to cell cycle regulation and neuritic plaques.
- Breast cancer PRS linked to angiogenesis and atherosclerosis, and signal transduction with TDP-43 pathology.
- Liver cancer PRS associated with apoptotic processes and Braak stage.
- Lung cancer PRS connected to chromatin organization and Braak stage, and memory biological processes with neuritic plaques.
- Colon cancer PRS linked to hippocampus development and hemopoiesis, both with neuritic plaques.
Limitations and Future Work
- Selection and Survival Bias: The authors acknowledge that selection and survival biases cannot be entirely ruled out as potential contributors to the observed inverse relationship. Individuals who survive cancer might represent a healthier sub-population, or the treatments for cancer might have unforeseen effects on AD risk.
- Causality: The study identifies associations, not direct causation. Further research is needed to establish causal links.
- Future Directions: The authors suggest that future research should continue to explore these underlying mechanisms, potentially by incorporating cancer PRS more directly into analyses of AD. This could involve more detailed investigations into the identified pathways and their specific roles in both diseases.
Summary updated